This is a case report of a 41-year-old male with progressive facial numbness, eyelid closure weakness, slurred speech, and dysphagia over 6 years, leading to a diagnosis of FOSMN.
Medicine · 7 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This is a case report of a 41-year-old male with progressive facial numbness, eyelid closure weakness, slurred speech, and dysphagia over 6 years, leading to a diagnosis of FOSMN.
This is a case report of a 41-year-old male with progressive facial numbness, eyelid closure weakness, slurred speech, and dysphagia over 6 years, leading to a diagnosis of FOSMN. Testing also revealed positive anti-AchR and anti-titin antibodies, a positive neostigmine test, and abnormal repetitive nerve stimulation, indicating comorbid MG. Treatment with pyridostigmine bromide and prednisolone led to improvement in symptoms for at least 4 months. The authors note that FOSMN is often considered neurodegenerative, while MG is autoimmune. The report highlights this rare co-occurrence and suggests a possible immune-mediated pathogenesis, though evidence is limited to this single case.